-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
GOLDENWELL BIOTECH, INC. quarterly and annual Revenues in USD history and change rate from 30 Sep 2019 to 30 Sep 2025.
- GOLDENWELL BIOTECH, INC. Revenues for the quarter ending 30 Sep 2025 was $0.
- GOLDENWELL BIOTECH, INC. annual Revenues for 2024 was $139, a 92% decline from 2023.
- GOLDENWELL BIOTECH, INC. annual Revenues for 2023 was $1,836, a 96% decline from 2022.
- GOLDENWELL BIOTECH, INC. annual Revenues for 2022 was $47,800, a 199% increase from 2021.